The UK not-for-profit organisation, Heroic Hearts, is to undertake groundbreaking research exploring the potential of psilocybin for treating traumatic brain injury in veterans.
Psychedelics company Silo Wellness has today announced a UK distribution partnership for its Marley One functional mushroom products.
Awakn Life Sciences has announced the opening of its second psychedelic therapy clinic that will be located in London.
A quantum drug development programme has been launched by psychedelic healthcare company PsiloThera.
A Canadian psychedelics company has received approval to move to the top tier of the TSX Venture Exchange market.
Psychedelics company Eastra Health has appointed a new chief scientific officer.
A groundbreaking new centre at the University of California will boost the study of psychedelics as a treatment for brain health.
American medical cannabis company Goodness Growth Holdings has announced it is branching out in to psychedelics medicine.
Delic Holdings Inc, a psychedelic wellness platform, has acquired Ketamine Infusion Centers LLC (“KIC”) as it looks to expand.
A national poll has revealed a clear majority of people in the UK are in favour of research into the medical potential of psilocybin.